{
  "trial_id": "NCT00423592",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, diagnosis (IPAH, FPAH, PAH associated with collagen vascular disease, congenital systemic-to-pulmonary shunts, anorexigen use, HIV infection), previous ERA therapy (bosentan or sitaxsentan), baseline serum ALT concentration, baseline serum AST concentration, six-minute walk distance, use of sildenafil or prostanoid therapy, HIV status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Pulmonary Arterial Hypertension Etiology",
          "diagnosis (IPAH, FPAH, PAH associated with collagen vascular disease, congenital systemic-to-pulmonary shunts, anorexigen use, HIV infection)"
        ],
        [
          "Pulmonary Arterial Hypertension Treatment",
          "previous ERA therapy (bosentan or sitaxsentan)"
        ],
        [
          "Baseline 6-Minute Walk Distance",
          "six-minute walk distance"
        ],
        [
          "Pulmonary arterial hypertension present",
          "HIV status."
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "World Health Organization (WHO) Functional Class",
        "Body Mass Index",
        "Borg dyspnea index",
        "Cardiac index",
        "Height",
        "Mean pulmonary artery pressure",
        "Pulmonary capillary wedge pressure",
        "Pulmonary vascular resistance",
        "Right atrial pressure",
        "Weight"
      ],
      "remaining_candidate_features": [
        "baseline serum ALT concentration",
        "baseline serum AST concentration",
        "use of sildenafil or prostanoid therapy"
      ]
    },
    "processed-gen-response": "Age, gender, diagnosis (IPAH, FPAH, PAH associated with collagen vascular disease, congenital systemic-to-pulmonary shunts, anorexigen use, HIV infection), previous ERA therapy (bosentan or sitaxsentan), baseline serum ALT concentration, baseline serum AST concentration, six-minute walk distance, use of sildenafil or prostanoid therapy, HIV status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline serum ALT, Baseline serum AST, Six-minute Walk distance, Type of PAH (IPAH, FPAH, or associated conditions), Use of sildenafil or prostanoids, HIV status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline 6-Minute Walk Distance",
          "Six-minute Walk distance"
        ],
        [
          "Pulmonary Arterial Hypertension Etiology",
          "Type of PAH (IPAH, FPAH, or associated conditions)"
        ],
        [
          "Pulmonary Arterial Hypertension Treatment",
          "Use of sildenafil or prostanoids"
        ]
      ],
      "remaining_reference_features": [
        "World Health Organization (WHO) Functional Class",
        "Body Mass Index",
        "Borg dyspnea index",
        "Cardiac index",
        "Height",
        "Mean pulmonary artery pressure",
        "Pulmonary arterial hypertension present",
        "Pulmonary capillary wedge pressure",
        "Pulmonary vascular resistance",
        "Right atrial pressure",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Baseline serum ALT",
        "Baseline serum AST",
        "HIV status"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline serum ALT, Baseline serum AST, Six-minute Walk distance, Type of PAH (IPAH, FPAH, or associated conditions), Use of sildenafil or prostanoids, HIV status"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Six-minute Walk distance, Pulmonary Arterial Hypertension diagnosis, Previous ERA therapy discontinuation, Serum ALT and AST concentrations at screening,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Baseline 6-Minute Walk Distance",
          "Six-minute Walk distance"
        ],
        [
          "Pulmonary Arterial Hypertension Etiology",
          "Pulmonary Arterial Hypertension diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Pulmonary Arterial Hypertension Treatment",
        "World Health Organization (WHO) Functional Class",
        "Borg dyspnea index",
        "Cardiac index",
        "Height",
        "Mean pulmonary artery pressure",
        "Pulmonary arterial hypertension present",
        "Pulmonary capillary wedge pressure",
        "Pulmonary vascular resistance",
        "Right atrial pressure",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Previous ERA therapy discontinuation",
        "Serum ALT and AST concentrations at screening"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Six-minute Walk distance, Pulmonary Arterial Hypertension diagnosis, Previous ERA therapy discontinuation, Serum ALT and AST concentrations at screening"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), six-minute walk distance, PAH diagnosis (IPAH, FPAH, or PAH associated with collagen vascular disease, congenital systemic-to-pulmonary shunts, anorexigen use, HIV infection), prior ERA therapy (bosentan or sitaxsentan), concomitant PAH medications (sildenafil, prostanoid), HIV disease status, serum ALT and AST concentrations at screening.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Weight",
          "weight"
        ],
        [
          "Height",
          "height"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Baseline 6-Minute Walk Distance",
          "six-minute walk distance"
        ],
        [
          "Pulmonary Arterial Hypertension Etiology",
          "PAH diagnosis (IPAH, FPAH, or PAH associated with collagen vascular disease, congenital systemic-to-pulmonary shunts, anorexigen use, HIV infection)"
        ],
        [
          "Pulmonary Arterial Hypertension Treatment",
          "prior ERA therapy (bosentan or sitaxsentan)"
        ],
        [
          "Pulmonary Arterial Hypertension Treatment",
          "concomitant PAH medications (sildenafil, prostanoid)"
        ],
        [
          "Pulmonary arterial hypertension present",
          "serum ALT and AST concentrations at screening."
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "World Health Organization (WHO) Functional Class",
        "Borg dyspnea index",
        "Cardiac index",
        "Mean pulmonary artery pressure",
        "Pulmonary capillary wedge pressure",
        "Pulmonary vascular resistance",
        "Right atrial pressure"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "HIV disease status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), six-minute walk distance, PAH diagnosis (IPAH, FPAH, or PAH associated with collagen vascular disease, congenital systemic-to-pulmonary shunts, anorexigen use, HIV infection), prior ERA therapy (bosentan or sitaxsentan), concomitant PAH medications (sildenafil, prostanoid), HIV disease status, serum ALT and AST concentrations at screening."
  }
}